The Leading Source for Pharmaceutical & Biopharmaceutical Manufacturing News
Subscribe to Pharmaceutical Processing
View Sample

FREE Daily Email Newsletter

Australia to Withhold Payments from Parents Against Vaccine

April 14, 2015 10:54 am | by Rod McGuirk, Associated Press | News | Comments

The crackdown comes as similar moves to limit vaccination waivers in the United States have proved to be deeply divisive.


Norovirus Sickens 200 on Cruise Ships

April 14, 2015 10:49 am | by The Associated Press | News | Comments

Federal health officials say about 200 people have come down with vomiting and diarrhea aboard two San Diego-bound cruise ships.


Actavis: No Apologies for Seeking Alzheimer's Drug Profits

April 14, 2015 10:45 am | by Larry Neumeister, Associated Press | News | Comments

A lawyer for Actavis urged a U.S. appeals court on Monday to let it replace a two-pill daily regimen with a single-dose version of the drug even if it cheats generic drugmakers of profits.


SD30 Attritor for Reactive Milling

April 13, 2015 4:05 pm | by Union Process | Product Releases | Comments

Union Process, Inc. has manufactured an SD30 dry grinding Attritor for a customer who is using the mill for reactive milling.

Specialty, Generic Drug Costs Drive Medicaid Costs Up

April 13, 2015 4:01 pm | by MARIE FRENCH, Associated Press | News | Comments

The high cost of a drug used to treat Medicaid patients with hepatitis C drew scrutiny from lawmakers earlier this year, but other drugs are also driving up the state's costs and likely will continue to do so for several years, government data reveals.


FDA Confirms Change of Ownership of 23 US Generic Drugs

April 13, 2015 3:54 pm | by PR Newswire | News | Comments

IDT Australia Limited announced that the U.S. Food and Drug Administration (FDA) has confirmed receipt of the change of ownership letters formally transferring ownership of the 23 generic drug products to IDT.


Cipher Pharmaceuticals to Acquire INNOCUTIS

April 13, 2015 3:26 pm | by PR Newswire | News | Comments

Cipher Pharmaceuticals Inc. announced it has acquired INNOCUTIS Holdings LLC, a privately held specialty dermatology company, for $45.5 million in cash.


ND Measure Allows Patients to Try Experimental Treatments

April 13, 2015 3:17 pm | by The Associated Press | News | Comments

North Dakota's Legislature has passed a measure that gives patients the chance to try experimental drugs that haven't gotten final approval for general use from the U.S. Food and Drug Administration.


Hi-Tech Pharmaceuticals To Acquire Advanced Pharmaceuticals and Nutritionals

April 13, 2015 3:13 pm | by PRNewswire | News | Comments

The companies said the acquisition creates a top-tiered global OTC pharmaceutical and nutraceutical company.


Roche Acquires CAPP Medical

April 13, 2015 1:33 pm | by Roche | News | Comments

Roche has acquired CAPP Medical, a genomics research company founded by Stanford University oncologists and industry veterans.


Cancer Surge in China Prompts Rise of Special Patient Hotels

April 13, 2015 1:29 pm | by Jack Chang, Associated Press | News | Comments

Many so-called cancer hotels dot the neighborhoods around Chinese hospitals, giving patients an affordable, cozy place to wait for appointments and undergo outpatient treatment.


Survey: Nearly 9 in 10 U.S. Adults Now Have Health Insurance

April 13, 2015 1:25 pm | by Ricardo Alonso-Zaldivar, Associated Press | News | Comments

Underlining a change across the nation, nearly 9 out of 10 adults now say they have health insurance, according to an extensive survey released Monday.


Hazardous Bulk Bag Conditioning System

April 13, 2015 1:18 pm | by Material Transfer | Product Releases | Comments

The Material Master system utilizes "v-shaped" tubular breaker profiles to efficiently return even the most severely agglomerated materials to a free-flowing state.

BIOSTAT D-DCU fermentor/bioreactor

April 13, 2015 1:11 pm | by Sartorius Stedim Biotech | Product Releases | Comments

Sartorius Stedim Biotech, a global supplier of the biopharmaceutical industry, has launched a new version of its proven stainless steel fermentor/bioreactor BIOSTAT D-DCU.

Neothetics Clinical Trials for Ab Fat Drug

April 13, 2015 1:03 pm | News | Comments

Neothetics initiated Phase 3 trials of a non-invasive injectable for reduction of central abdominal bulging due to subcutaneous fat.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.